Yesway Announces Launch of Initial Public Offering
Morgan Stanley is acting as lead bookrunning manager for the offering. J.P. Morgan and Goldman Sachs & Co. LLC are acting as active bookrunning managers. Barclays, BMO Capital Markets, KeyBanc Capital Markets, Guggenheim Securities, and Raymond James & Associates, Inc. are also acting as bookrunners.
The offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained from any of the following sources:
- Morgan Stanley & Co. LLC
Attention: Prospectus Department180 Varick Street , Second FloorNew York, New York 10014 - J.P. Morgan Securities LLC
c/o Broadridge Financial Solutions1155 Long Island Avenue Edgewood, New York 11717
Email: [email protected] or [email protected] - Goldman Sachs & Co. LLC
Attention: Prospectus Department200 West Street New York, New York 10282
Telephone: 1-866-471-2526
Email: [email protected]
A registration statement on Form S-1 relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Yesway - Established in 2015 and headquartered in
Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/yesway-announces-launch-of-initial-public-offering-302740458.html
SOURCE Yesway
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erasca prices upsized stock offering at $17.50 per share
- Haoxi Health closes $4M direct offering via Univest Securities
- Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
JPMorgan, Goldman Sachs, KeyBanc, Raymond James, Morgan Stanley, BMO Capital, Barclays, S1, IPO, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share